Detail of the clinical trial

Title of the trial A Phase 3 Randomized, Open-Label Study of Ponatinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
EudraCT number 2012-001355-38
Protocol number AP24534-12-301
Sponsor Ariad Pharmaceticals, Inc., 26 landsdowne Street, MA 02139 Cambridge, USA
Indications Hemato-oncology
Diagnosis Chronic Myeloid Leukemia in Chronic Phase
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2012
Date of approval by Institute (SÚKL) 17.12.2012
Date of approval by EC 12.12.2012
Date of initiation CT in ČR
Date of ending CT in ČR 30.10.2013 (17.10.2013)
Ústav hematologie a krevní transfuze
Fakultní nemocnice Hradec Králové, IV. interní hematologická klinika
Fakultní nemocnice Brno, Interní hematologická a onkologická klinika

‹‹ Back to list